Clinical Trial Update: A Specification Clinical Application Research of Tripterygium Wilfordii Treating Rheumatoid Arthritis [Phase 2, Phase 3]

View source ↗

Summary

This document reports on a Phase 2/Phase 3 clinical trial evaluating Tripterygium wilfordii for rheumatoid arthritis. The current status of the trial is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Tripterygium wilfordii (Tripterygium wilfordii)

Snippet

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical Sciences | Conditions: Rheumatoid Arthritis | Phase 2, Phase 3 | Status: UNKNOWN